Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference2%
- Check53 days agoChange DetectedSeveral key URLs related to genetics, lung cancer, and clinical trials have been removed, indicating a significant reduction in available resources for these topics.SummaryDifference3%
- Check60 days agoChange DetectedNew resources related to lung cancer, including links to MedlinePlus, DailyMed, and PubMed articles, have been added, enhancing access to important medical information.SummaryDifference0.6%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.